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L U M E  5     M A Y
Tools/Aps & Jobs
INITIAL ANALYSIS OF THE PHASE II/III TEENCOVE STUDY
OF MODERNA ’S MRNA VACCINE , IN WHICH UMASS
MEDICAL SCHOOL IS PARTICIPATING , SHOWED VACCINE
EFFICACY AGAINST COVID-19 OF 96 PERCENT AND THE
VACCINE WAS GENERALLY WELL TOLERATED WITH NO
SERIOUS SAFETY CONCERNS IDENTIFIED TO DATE , THE
COMPANY REPORTED IN A BUSINESS UPDATE MAY 6 . 
 THE STUDY , WHICH HAS COMPLETED ENROLLMENT ,
INCLUDED ADOLESCENTS AGES 12 TO 17 IN THE UNITED
STATES . PARTICIPANTS WERE RANDOMIZED WITH TWICE
AS MANY RECEIVING THE VACCINE AS THE NUMBER
WHO RECEIVED THE PLACEBO . INITIAL ANALYSES WERE
REPORTED FOR 3 ,235 PARTICIPANTS WHO RECEIVED AT
LEAST ONE INJECTION . FULL ARTICLE
EARLY DATA FROM TEENCOVE STUDY SHOWS
MODERNA COVID-19 VACCINE EFFECTIVE, SAFE
FOR AGES 12-17 -  BY  SUSAN  E .W .  SPENCER
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EVENTS
We are excited to announce our upcoming second annual CAPCaT
Showcase and look forward to welcoming you on June 17th.   Read all
about this year’s compelling program, claim your invitation and register
here: 2021 CAPCaT Big Company/Little Company Showcase Tickets, Thu,
Jun 17, 2021 at 9:00 AM | Eventbrite.
Attendees will hear about nine breakthrough point-of-care innovations and
learn about strategic partnership and grant opportunities that are
accelerating medical science innovation.
CENTER FOR ADVANCING POINT OF CARE
TECHNOLOGIES
THURSDAY ,  JUNE  17TH
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Join the National Center for Advancing Translational Sciences (NCATS) in
collaboration with University of Massachusetts Medical School on
Wednesday, June 9, 2021, for a webinar to learn about the Small Business
Innovation Research and Small Business Technology Transfer (SBIR/STTR)
programs for researchers and entrepreneurs in translational science.
NCATS offers non-dilutive funding and resources to help small businesses
advance and commercialize promising translational biotech and life
sciences research technologies. If you are a researcher in these fields and
are interested in bringing your innovations to market you may be eligible
to apply to the NCATS SBIR and STTR programs.
Register now to join the webinar, Small Business Resources and SBIR/STTR
Funding to Drive Commercialization in Translational Science on
Wednesday, June 9, 2021, 2:30 – 3:30 p.m. ET
NCATS INVITES YOU TO:  SMALL BUSINESS RESOURCES AND
SBIR/STTR FUNDING TO DRIVE COMMERCIALIZATION IN
TRANSLATIONAL SCIENCE
WEDNESDAY ,  JUNE  9TH ,  2 :30-3 :30  PM
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Zoom Link: 
https://umassmed.zoom.us/j/98699860149?pwd=MWlyanlueDBBR05MNE90azRlZHVWUT09
Contact Melissa Corash at Melissa.BrewerCorash@umassmed.edu for
further details.
 
    
We cordially invite you to attend the virtual
Projects in Process Seminar Series (PiPSS)
taking place on Friday afternoons from 11 AM
to 12 PM.  The series will feature presentations
from our TL1, Millennium, MSCI and KL2
scholars on their various research projects. 
PROJECTS IN PROCESS SEMINAR SERIES (PIPSS)
FRIDAYS  MARCH  5TH  TO  JUNE  11TH  2021
EVENTS
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NOT-OD-21-097 – (Released March 29, 2021) Notice of Intent to Publish a
Research Opportunity Announcement for RADxSM-UP Return to School
Diagnostic Testing Approaches (OT2 Clinical Trial Optional)
The purpose of this Notice is to alert the community that NIH plans to
publish a Research Opportunity (RO) as part of the Rapid Acceleration of
Diagnostics for Underserved Populations (RADxSM-UP) initiative to solicit
research on COVID-19 diagnostic testing approaches to safely return children
and staff to the in-person school setting in underserved and vulnerable
communities (NOT-OD-21-065).
Due Date: Applicants will be invited for the full proposal stage by April 23,
2021 with a receipt date for the full proposal on May 14, 2021.
RFA-OD-21-009 – (Released April 13, 2021) Emergency Award: RADx-UP - Social,
Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19
Testing among Underserved and Vulnerable Populations (U01 Clinical Trials
Optional)
This Phase II RADx-UP Funding Opportunity Announcement (FOA) is
designed to expand research to understand and address the social, ethical,
and behavioral implications (SEBI) of COVID-19 testing interventions among
underserved and vulnerable populations. Desirable studies for Phase II will
move beyond descriptive health disparities research to focus on developing
interventions and other actionable solutions in collaboration with
community partners and stakeholders.
Due Date: July 7, 2021
RADX- UP FUNDING OPPORTUNITES  
VARIOUS  DUE  DATES
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FUNDING
RFA-OD-21-008 – (Released April 13, 2021) Emergency Awards: Community-
engaged COVID-19 Testing Interventions among Underserved and Vulnerable
Populations- RADxSM-UP Phase II (U01, Clinical Trial Optional)
This funding opportunity announcement (FOA) uses an emergency U01
mechanism to support Phase II of the Rapid Acceleration of Diagnostics –
Underserved Populations (RADxSM-UP) initiative. These two-year Testing
Research Projects will (1) expand the scope and reach of RADxSM-UP testing
interventions to reduce COVID-19 disparities among underserved and
vulnerable populations and (2) address scientific questions on interventions
to increase access and uptake of COVID-19 testing given the increasing
availability of SARS-CoV-2 vaccines
Due Date: July 7, 2021
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NOT-OD-21-103 – (Released April 13, 2021) Notice of Special
Interest (NOSI): Emergency Competitive Revisions for NIH
Grants to Add or Expand Community-engaged COVID-19
Testing Interventions among Underserved and Vulnerable
Populations – RADxSM-UP Phase II (Emergency Supplement-
Clinical Trial Optional)
The National Institutes of Health (NIH) are issuing this
NOSI in response to the declared public health
emergency issued by the Secretary, HHS, for 2019 Novel
Coronavirus (COVID-19). This NOSI provides an expedited
funding mechanism to support Phase II of the Rapid
Acceleration of Diagnostics – Underserved Populations
(RADxSM-UP) initiative. These two-year Testing Research
Projects will (1) expand the scope and reach of RADxSM-
UP testing interventions to reduce COVID-19 disparities
among underserved and vulnerable populations and (2)
address scientific questions on interventions to increase
access and uptake of COVID-19 testing given the
increasing availability of SARS-CoV-2 vaccines.
Due Date: Applications may be submitted beginning on
May 1, 2021 for an Application Due Date of May 24,
2021(5:00 PM local time of the applicant organization).
Applications received after May 24, 2021 will not be
considered.
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FUNDING
RADX- UP FUNDING OPPORTUNITES  
VARIOUS  DUE  DATES
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NOT-OD-21-101- (Released April 13, 2021) Notice of Special Interest (NOSI):
Administrative Supplements for Rapid Acceleration of Diagnostics-Underserved
Populations (RADxSM-UP) Phase I Projects to Address Vaccine Hesitancy and
Uptake
This Notice of Special Interest (NOSI) seeks to support administrative
supplements to Rapid Acceleration of Diagnostics-Underserved Populations
(RADxSM-UP) recipients to address the urgent need to expand outreach and
education efforts to promote testing and foster vaccine confidence,
acceptance, and uptake in underserved and vulnerable communities. These
1-year projects will develop, implement, and evaluate brief interventions at
RADxSM-UP testing sites to maximize effective outreach, education,
communication, and facilitate the dissemination and uptake of testing and
vaccines in underserved and vulnerable communities.
Eligibility: Applications are being requested from current RADx-UP recipients
from the following Funding Opportunity Announcements and Notices of
Special Interest:
NOT-OD-20-121- Notice of Special Interest (NOSI): Limited Competition for
Emergency Competitive Revisions for Community-Engaged Research on
COVID-19 Testing among Underserved and/or Vulnerable Populations
NOT-OD-20-120- Notice of Special Interest (NOSI): Emergency Competitive
Revisions for Community-Engaged Research on COVID-19 Testing among
Underserved and/or Vulnerable Populations
NOT-OD-20-119- Notice of Special Interest (NOSI): Emergency Competitive
Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research
on COVID-19 Testing among Underserved and/or Vulnerable Populations
Funds available: Individual requests can be no more than $300,000 in total
costs per year for up to one year. Funds are available for up to 15 awards.
Due Date: Applications will be accepted on a rolling basis through May 10
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FUNDING
RADX- UP FUNDING OPPORTUNITES  
VARIOUS  DUE  DATES
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RedCap is a user friendly tool for building online surveys and databases which is
utilized most often in the field of clinical research. 
There is a self-paced REDCap online training wiki available for REDCap users.  
Request a REDCap account by clicking here.  
Request REDCap support by creating a ticket here.
The DL&I Incubator team is pleased to announce the launch of Training
Opportunities To Augment Learning (TOTAL), a digital app that allows biomedical
trainees to attend career and professional development events held at Boston
University and eight Boston-based partner institutions.  Click here to read more.
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EDUCATION
The NCI-funded PRACCTIS program (Prevention and Control of Cancer:
Training for Change in Individuals and Systems) at UMMS is now accepting
applications for postdoctoral scholars to start January 2021 and August 2021.
We train independent researchers to address critical prevention and control
care delivery issues across the cancer continuum, including primary prevention,
screening, diagnosis, treatment and survivorship, with emphasis on promoting
change in individuals, providers and systems. Our faculty mentors are leaders
in implementation science, health equity and low resource settings, health
behavior change, health informatics, systems change and health policy, health
communications, population health sciences, and prevention and intervention
research. Applicants must plan to pursue an independent research career focused
on cancer prevention and control, have earned a doctoral degree (PhD, ScD, MD,
DO, etc.), and be a U.S. citizen or permanent resident. For more information contact
Barbara Estabrook, Barbara.estabrook@umassmed.edu .
POSTDOCTORAL TRAINING IN CANCER 
PREVENTION & CONTROL
MAY 2021 PAGE | 08
U M A S S  C C T S  N E W S L E T T E R
Tufts CTSI Clinical Research Network is hosting the “Research with Sexual and
Gender Minority Populations” training module which will be led by Tania D. Strout,
PhD, RN, MS from Maine Medical Center.  Please register at:
https://ilearn.tuftsctsi.org/product?catalog=ST109_2019_Online
RESEARCH WITH SEXUAL & GENDER MINORITY POPULATIONS
Please cite the NIH CTSA award any time you use The UMMS Center for
Clinical and Translational Science resources, services and facilities or
received funding through the Center. “The project described is
supported by the National Center for Advancing Translational Sciences,
National Institutes of Health, through Grant UL1 TR001453, (or TL1
TR001454, or KL2 TR001455, as appropriate). The content is solely the
responsibility of the authors and does not necessarily represent the
official views of the NIH.”
CITE & SUBMIT
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V O L .  1  J A N U A R Y   2 0 2 1
SHARE YOUR SUCCESS STORY!
Have you had your research published that cites
the UMass Center for Clinical and Translational
Science?  Has your patent been filed on technology
developed using Center funding or resources? Did
your pilot project receive external grant funding?
Share it with us at ccts@umassmed.edu. Sharing
your success demonstrates the importance and
effect of the Center for Clinical and Translational
Science at UMass.
CENTER FOR CLINICAL &
TRANSLATIONAL SCIENCE
U M A S S  C C T S  N E W S  L E T T E R
To be included in the CCTS Monthly Newsletter , please send announcements ,
including a link , to ccts@umassmed .edu . The newsletter is published the first
week of each month .
NEWSLETTER SUBMISSIONS
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UNIVERSITY  OF  MASSACHUSETTS  CENTER  FOR  CLINICAL  AND  TRANSLATIONAL  SCIENCE
 55  LAKE  AVENUE  N ,  WORCESTER  MA  01655
KATHERINE LUZURIAGA, MD
PI  AND  DIRECTOR ,  UMCCTS  
TERENCE R. FLOTTE, MD   
 CO-DIRECTOR ,  UMCCTS
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